Drug inspections not targeting India, says U.S. FDA official

08/30/2013 | Business Standard (India)

The U.S. FDA is working to ensure that all pharmaceutical imports are safe, effective and of the highest quality, and is not targeting Indian companies for tougher treatment than other firms, said Altaf A. Lal, director of the agency's India office. He noted that of four recent deficiency notices, two were for Indian companies, one was American and the other German. The FDA has 12 inspectors -- soon, 19 -- who are based in New Delhi and Mumbai.

View Full Article in:

Business Standard (India)

Published in Brief:

SmartBrief Job Listings for Health Care